West Pharmaceutical Services | WST - Operating Expenses


West Pharmaceutical Services reported $2.99B in Operating Expenses for its fiscal quarter ending in June of 2026.





Operating Expenses Change Date
Align Technology USD 864.87M 2.84M Jun/2026
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.42B 283M Jun/2026
Cerus USD 34.78M 2.98M Dec/2024
Charles River Laboratories USD 2.84B 1.96B Jun/2026
Cooper Companies USD 844.2M 268.3M Jun/2026
Dentsply International USD 1.35B 33M Jun/2026
Haemonetics USD 145.34M 148.66M Jun/2026
ICU Medical USD 491.25M 8.59M Jun/2026
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 368.53M 674.84M Sep/2026
IQVIA Holdings USD 1.77B 4.45B Jun/2026
J&J USD 18.93B 1.09B Sep/2026
Medtronic USD 7.92B 203M Jun/2026
Merit Medical Systems USD 358.44M 20.72M Jun/2026
Neogen USD 224.6M 2.4M Jun/2026
OraSure Technologies USD 40.35M 2.45M Dec/2025
Quidel USD 646.2M 1.21B Jun/2026
Repligen USD 183M 8.72M Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
Solventum Corp USD 4.8B 169M Jun/2026
STAAR Surgical USD 83.43M 7.32M Jun/2026
Terumo JPY 222.33B 46.54B Jun/2026
Utah Medical Products USD 6.16M 447K Mar/2026
West Pharmaceutical Services USD 2.99B 200K Jun/2026